Anchiano Therapeutics Ltd.
(NASDAQ CM: ANCN)
Rigrodsky Law, P.A. is investigating Anchiano Therapeutics Ltd. ("Anchiano") regarding possible breaches of fiduciary duties and other violations of law related to Anchiano's agreement to merge with Chemomab Ltd. ("Chemomab"). Under the terms of the agreement, Anchiano will issue a number of American Depository Shares of Anchiano to shareholders of Chemomab. Upon the closing of the merger, shareholders of Chemomab are expected to own approximately 90% of the outstanding shares of Anchiano.